Your browser doesn't support javascript.
loading
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK).
Nemes, Karolina; Bens, Susanne; Kachanov, Denis; Teleshova, Margarita; Hauser, Peter; Simon, Thorsten; Tippelt, Stephan; Woessmann, Wilhelm; Beck, Olaf; Flotho, Christian; Grigull, Lorenz; Driever, Pablo H; Schlegel, Paul-Gerhardt; Khurana, Claudia; Hering, Kathrin; Kolb, Reinhard; Leipold, Alfred; Abbink, Floor; Gil-Da-Costa, Maria J; Benesch, Martin; Kerl, Kornelius; Lowis, Stephen; Marques, Carmen H; Graf, Norbert; Nysom, Karsten; Vokuhl, Christian; Melchior, Patrick; Kröncke, Thomas; Schneppenheim, Reinhard; Kordes, Uwe; Gerss, Joachim; Siebert, Reiner; Furtwängler, Rhoikos; Frühwald, Michael C.
Afiliação
  • Nemes K; Paediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Medical Center Augsburg, Germany.
  • Bens S; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Ulm, Germany.
  • Kachanov D; National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Moscow, Russian Federation.
  • Teleshova M; National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Moscow, Russian Federation.
  • Hauser P; Department of Pediatric Oncology, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Simon T; Department of Pediatric Hematology and Oncology, University Children's Hospital of Cologne, Cologne, Germany.
  • Tippelt S; Department of Pediatric Hematology and Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany.
  • Woessmann W; Department of Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Beck O; Department of Pediatric Hematology, Oncology & Hemostaseology, University Medical Center of the Johannes Gutenberg-University Mainz, Germany.
  • Flotho C; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium, Heidelberg, Germany.
  • Grigull L; Department of Pediatric Hematology and Oncology, Children's Hospital of Hannover, Hannover, Germany.
  • Driever PH; Department of Pediatric Oncology and Hematology, Charité - University Hospital Berlin, Corporate Member of Free University Berlin, Humboldt-University Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Schlegel PG; Department of Pediatric Hematology and Oncology, University Würzburg, Würzburg, Germany.
  • Khurana C; Department of Pediatric Hematology and Oncology, Children's Hospital of Bielefeld, Germany.
  • Hering K; Department of Radiotherapy and Radiation Oncology, Leipzig University, Leipzig, Germany.
  • Kolb R; Department of Pediatrics, Children's Center, Hospital of Oldenburg, Oldenburg, Germany.
  • Leipold A; Children's Hospital Karlsruhe, Karlsruhe, Germany.
  • Abbink F; Department of Pediatric Hematology and Oncology, VU University Medical Center, Amsterdam, the Netherlands.
  • Gil-Da-Costa MJ; Pediatric Hemathology and Oncology Division, University Hospital S. João Alameda Hernani Monteiro, Porto, Portugal.
  • Benesch M; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Austria.
  • Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
  • Lowis S; School of Clinical Sciences, University of Bristol, London, UK.
  • Marques CH; Pediatric Onco-hematology Unit, Niño Jesús Hospital, Madrid, Spain.
  • Graf N; Department of Pediatric Hematology and Oncology, University of Saarland, Homburg, Germany.
  • Nysom K; Department of Paediatrics and Adolescent Medicine, Neuroscience Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Vokuhl C; Department of Pathology, Section of Pediatric Pathology, University Hospital Bonn, Bonn, Germany.
  • Melchior P; Department of Radiation Oncology, University of Saarland, Homburg, Germany.
  • Kröncke T; Department of Diagnostic and Interventional Radiology, University Hospital Augsburg, Augsburg, Germany.
  • Schneppenheim R; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kordes U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Gerss J; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Siebert R; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Ulm, Germany.
  • Furtwängler R; Department of Pediatric Hematology and Oncology, University of Saarland, Homburg, Germany.
  • Frühwald MC; Paediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Medical Center Augsburg, Germany. Electronic address: Michael.fruehwald@uk-augsburg.de.
Eur J Cancer ; 142: 112-122, 2021 01.
Article em En | MEDLINE | ID: mdl-33249395

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumor Rabdoide Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumor Rabdoide Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido